MYB and acute lymphoblastic leukemia: Since MYB and TAL1 co-occupy approximately 80% of TAL1 binding sites throughout the whole genome and form positive interconnected autoregulatory loops via binding to each other’s enhancers, it can be concluded that MYB together with the TAL1 complex serve as core regulatory circuitry in T-ALL.